Cargando…
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of currently used drugs represent major barriers that need to be overcome to provide a viable cure. Nanomedicines (NMeds)...
Autores principales: | Duskey, Jason Thomas, Rinaldi, Arianna, Ottonelli, Ilaria, Caraffi, Riccardo, De Benedictis, Chiara Alessia, Sauer, Ann Katrin, Tosi, Giovanni, Vandelli, Maria Angela, Ruozi, Barbara, Grabrucker, Andreas Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325049/ https://www.ncbi.nlm.nih.gov/pubmed/35890345 http://dx.doi.org/10.3390/pharmaceutics14071450 |
Ejemplares similares
-
Tunneling Nanotubes: A New Target for Nanomedicine?
por: Ottonelli, Ilaria, et al.
Publicado: (2022) -
Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
por: Pederzoli, Francesca, et al.
Publicado: (2019) -
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
por: Rinaldi, Arianna, et al.
Publicado: (2022) -
Microfluidic Technology for the Production of Hybrid Nanomedicines
por: Ottonelli, Ilaria, et al.
Publicado: (2021) -
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization
por: Rodà, Francesca, et al.
Publicado: (2023)